Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    January 2022
  1. CHAN JK, Tian C, Kesterson JP, Monk BJ, et al
    Symptoms of Women With High-Risk Early-Stage Ovarian Cancer.
    Obstet Gynecol. 2022 Jan 6. pii: 00006250-990000000-00358.
    PubMed     Abstract available


  2. GOFF BA
    Ovarian Cancer Is Not So Silent.
    Obstet Gynecol. 2022 Jan 6. pii: 00006250-990000000-00375.
    PubMed    


    December 2021
  3. NAZARETH S, Hayward L, Simmons E, Snir M, et al
    Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.
    Obstet Gynecol. 2021;138:860-870.
    PubMed     Abstract available


    November 2021
  4. BEDRICK BS, Fruhauf TF, Martin SJ, Ferriss JS, et al
    Creating Breast and Gynecologic Cancer Guidelines for Transgender Patients With BRCA Mutations.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00326.
    PubMed     Abstract available


    July 2021
  5. DIOUN S, Wu J, Chen L, Kaplan S, et al
    Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer: A Meta-analysis.
    Obstet Gynecol. 2021 Jul 8. pii: 00006250-990000000-00239.
    PubMed     Abstract available


    May 2021
  6. NITECKI R, Clapp MA, Fu S, Lamiman K, et al
    Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00202.
    PubMed     Abstract available


  7. ALHILLI MM, Pederson HJ
    Controversies in Hereditary Cancer Management.
    Obstet Gynecol. 2021;137:941-955.
    PubMed     Abstract available


    December 2020
  8. KURNIT KC, Fleming GF, Lengyel E
    Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004173.
    PubMed     Abstract available


    November 2020
  9. NITECKI R, Woodard T, Rauh-Hain JA
    Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies.
    Obstet Gynecol. 2020 Nov 5. doi: 10.1097/AOG.0000000000004163.
    PubMed     Abstract available


    September 2020

  10. Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation: Correction.
    Obstet Gynecol. 2020;136:638.
    PubMed    


    June 2020
  11. LUGO SANTIAGO N, Smith E, Cox M, Wan CS, et al
    Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation.
    Obstet Gynecol. 2020;135:1270-1274.
    PubMed     Abstract available


  12. JORGENSEN K, Schorge JO
    Too Good to Be True.
    Obstet Gynecol. 2020;135:1267-1269.
    PubMed    


    March 2020
  13. KINGSBERG SA, Larkin LC, Liu JH
    Clinical Effects of Early or Surgical Menopause.
    Obstet Gynecol. 2020 Mar 10. doi: 10.1097/AOG.0000000000003729.
    PubMed     Abstract available


    February 2020
  14. BRISTOW RE, Chang J, Villanueva C, Ziogas A, et al
    A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
    Obstet Gynecol. 2020 Feb 9. doi: 10.1097/AOG.0000000000003665.
    PubMed     Abstract available


  15. BULL PHELPS SL, Jackson-Moore LA
    Ovarian Cancer Care in the Affordable Care Act Era: Ovarian Cancer Breaking the Silence?
    Obstet Gynecol. 2020 Feb 9. doi: 10.1097/AOG.0000000000003679.
    PubMed    


  16. SMITH AJB, Fader AN
    Association of the Affordable Care Act With Ovarian Cancer Care.
    Obstet Gynecol. 2020 Feb 9. doi: 10.1097/AOG.0000000000003630.
    PubMed     Abstract available


    December 2019
  17. KURNIT KC, Sinno AK, Fellman BM, Varghese A, et al
    Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma.
    Obstet Gynecol. 2019;134:1253-1259.
    PubMed     Abstract available


    October 2019
  18. MATSUO K, Machida H, Yamagami W, Ebina Y, et al
    Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Obstet Gynecol. 2019 Oct 8. doi: 10.1097/AOG.0000000000003507.
    PubMed     Abstract available


    September 2019
  19. WILHITE AM, Oestreich MC, Olson M, Bedell SM, et al
    Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
    Obstet Gynecol. 2019;134:520-526.
    PubMed     Abstract available


    August 2019
  20. SHAFA A, Kumar A, Torres D, McKenzie TJ, et al
    Minimally Invasive Hysterectomy and Bariatric Surgery to Improve Endometrial Cancer Survivorship.
    Obstet Gynecol. 2019 Aug 7. doi: 10.1097/AOG.0000000000003403.
    PubMed     Abstract available



  21. Adnexal Torsion in Adolescents: ACOG Committee Opinion No, 783.
    Obstet Gynecol. 2019;134:e56-e63.
    PubMed     Abstract available



  22. Adnexal Torsion in Adolescents: ACOG Committee Opinion No, 783 Summary.
    Obstet Gynecol. 2019;134:435-436.
    PubMed     Abstract available


    June 2019
  23. SYEDA S, Chen L, Hou JY, Tergas AI, et al
    Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer.
    Obstet Gynecol. 2019 Jun 11. doi: 10.1097/AOG.0000000000003287.
    PubMed     Abstract available


    January 2019
  24. ROSE PG, Java JJ, Salani R, Geller MA, et al
    Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
    Obstet Gynecol. 2019 Jan 8. doi: 10.1097/AOG.0000000000003086.
    PubMed     Abstract available


    July 2018
  25. GIRAUDET G, Rubod C, Collinet P, Cosson M, et al
    Salpingectomy During Vaginal Hysterectomy: A Surgical Technique to Make It Easier.
    Obstet Gynecol. 2018 Jul 10. doi: 10.1097/AOG.0000000000002746.
    PubMed     Abstract available


    May 2018
  26. SAAVALAINEN L, Lassus H, But A, Tiitinen A, et al
    Risk of Gynecologic Cancer According to the Type of Endometriosis.
    Obstet Gynecol. 2018 May 7. doi: 10.1097/AOG.0000000000002624.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: